Sezary Disease clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma
Sorry, in progress, not accepting new patients
This is an open label, multi-cohort, and multi-center phase II study, which evaluates the clinical activity and safety of IPH4102 in Sezary Syndrome and Mycosis fungoides as single agent.
Los Angeles, California and other locations
Last updated: